Over 11,000 plasma and cerebrospinal fluid proteomic samples reveal that the APOE ε4 genetic variant is associated with a systemic pro-inflammatory signature in a variety of neurodegenerative diseases. This evidence concerns the gene APOE and neurodegenerative disease.